jCyte Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$3.87M
- Investors
-
2
jCyte General Information
Description
Developer of cell-based therapeutics intended to cure degenerative retinal disorders. The company's therapy uses retinal progenitor cells that secrete growth factors to rescue damaged retinal cells which helps in treating a degenerative eye disease and retinitis pigmentosa, enabling patients to preserve vision by intervening in the disease at a time when host photoreceptors can be protected and potentially reactivated.
Contact Information
Website
www.jcyte.comCorporate Office
- 23 Corporate Plaza Drive
- Suite 150
- Newport Beach, CA 92660
- United States
Corporate Office
- 23 Corporate Plaza Drive
- Suite 150
- Newport Beach, CA 92660
- United States
jCyte Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 01-Jan-2021 | $3.87M | Completed | Clinical Trials - Phase 3 | ||
| 4. Grant | 01-Dec-2019 | Completed | Clinical Trials - Phase 2 | |||
| 3. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 2. Grant | 17-Sep-2012 | $17.1M | Completed | Pre-Clinical Trials | ||
| 1. Grant | 01-Jan-2010 | $4M | Completed | Startup |
jCyte Patents
jCyte Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022217152-A1 | Low luminance mobility test | Pending | 03-Feb-2021 | ||
| CA-3207217-A1 | Low luminance mobility test | Pending | 03-Feb-2021 | ||
| EP-4287927-A1 | Low luminance mobility test | Active | 03-Feb-2021 | ||
| EP-4287927-B1 | Low luminance mobility test | Active | 03-Feb-2021 | ||
| EP-4691363-A2 | Low luminance mobility test | Pending | 03-Feb-2021 | A61B3/063 |
jCyte Signals
jCyte Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| California Institute for Regenerative Medicine | Government | |||
| UCI Beall Applied Innovation | Accelerator/Incubator |
jCyte FAQs
-
When was jCyte founded?
jCyte was founded in 2010.
-
Where is jCyte headquartered?
jCyte is headquartered in Newport Beach, CA.
-
What is the size of jCyte?
jCyte has 10 total employees.
-
What industry is jCyte in?
jCyte’s primary industry is Drug Discovery.
-
Is jCyte a private or public company?
jCyte is a Private company.
-
What is jCyte’s current revenue?
The current revenue for jCyte is .
-
How much funding has jCyte raised over time?
jCyte has raised $3.87M.
-
Who are jCyte’s investors?
California Institute for Regenerative Medicine and UCI Beall Applied Innovation have invested in jCyte.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process